Inventor

BUCKLEY DENNIS

US30 patents

⚠️ This page may combine multiple inventors who share the name “BUCKLEY DENNIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BUCKLEY DENNIS

DANA FARBER CANCER INST INC

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Targeted protein degradation using a mutant E3 ubiquitin ligase

Diazepane derivatives and uses thereof

Diazepane derivatives and uses thereof

Methods to induce targeted protein degradation through bifunctional molecules

Cyano thienotriazolodiazepines and uses thereof

Methods to induce targeted protein degradation through bifunctional molecules

Dihydropteridinone derivatives and uses thereof

Uses of diazepane derivatives

Regulating chimeric antigen receptors

Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses

Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use

Degradation of bromodomain-containing protein 9 (BRD9) by conjugation of BRD9 inhibitors with E3 ligase ligand and methods of use

Tunable endogenous protein degradation

Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use

Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use

Degradation of tripartite motif-containing protein 24 (TRIM24) by conjugation of TRIM24 inhibitors with E3 ligase ligand and methods of use

Tunable endogenous protein degradation with heterobifunctional compounds

CHILDRENS MEDICAL CT CORP

Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies

Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies

Calmodulin inhibitors, CHK2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies

UNIV YALE

Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase

REFLEX INSTR ASIA PACIFIC PTY LTD

Survey instrument